title: [Regional results of the program FORTISSIMO in Kazan].
authors.affiliation: Kazan State Medical University, ul. Butlerova 49, 420012 Kazan, Russia.
authors.forename: A S
authors.initials: AS
authors.lastname: Galiavich
authors.forename: R A
authors.initials: RA
authors.lastname: Galiavi
authors.forename: L V
authors.initials: LV
authors.lastname: Baleeva
mesh_terms: D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects; D001794:Blood Pressure / Q000187:drug effects*; D004338:Drug Combinations; D016903:Drug Monitoring; D004351:Drug Resistance; D005260:Female; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy / Q000453:epidemiology; D007190:Indapamide / Q000008:administration & dosage / Q000009:adverse effects; D008297:Male; D055118:Medication Adherence; D008875:Middle Aged; D020913:Perindopril / Q000008:administration & dosage / Q000009:adverse effects; D016730:Program Development; D011446:Prospective Studies; D012307:Risk Factors; D012426:Russia; D016896:Treatment Outcome
chemical_list: D000959:Antihypertensive Agents; D004338:Drug Combinations; C494243:indapamide, perindopril drug combination; D007190:Indapamide; D020913:Perindopril